Skip to content
10-K

Annual Report

Creative Medical Technology Holdings, Inc. CELZ

0001477932-26-001517

← back to feed
Filed
Mar 20, 2026 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Diluted FY 2025 · Dec 31, 2025 2.38M sh
Shares Diluted FY 2025 · Dec 31, 2024 1.48M sh
Stock Repurchased FY 2025 · Dec 31, 2025 $10K
Stock Repurchased FY 2025 · Dec 31, 2024 $174.96K
Operating Cash Flow FY 2025 · Dec 31, 2025 −$5.86M
Operating Cash Flow FY 2025 · Dec 31, 2024 −$5.3M
Stockholders Equity FY 2025 · Dec 31, 2025 $7.51M
Stockholders Equity FY 2025 · Dec 31, 2024 $6.34M
Current Liabilities FY 2025 · Dec 31, 2025 $284.88K
Current Liabilities FY 2025 · Dec 31, 2024 $327.64K
Total Liabilities FY 2025 · Dec 31, 2025 $284.88K
Total Liabilities FY 2025 · Dec 31, 2024 $327.64K
Current Assets FY 2025 · Dec 31, 2025 $7.4M
Current Assets FY 2025 · Dec 31, 2024 $6.14M
Total Assets FY 2025 · Dec 31, 2025 $7.81M
Total Assets FY 2025 · Dec 31, 2024 $6.67M
Eps Diluted FY 2025 · Dec 31, 2025 −$2.52
Eps Diluted FY 2025 · Dec 31, 2024 −$3.71
Sga Expense FY 2025 · Dec 31, 2025 $3.76M
Sga Expense FY 2025 · Dec 31, 2024 $3.24M
Rd Expense FY 2025 · Dec 31, 2025 $2.26M
Rd Expense FY 2025 · Dec 31, 2024 $2.4M
Net Income FY 2025 · Dec 31, 2025 −$6M
Net Income FY 2025 · Dec 31, 2024 −$5.49M
Operating Income FY 2025 · Dec 31, 2025 −$6.14M
Operating Income FY 2025 · Dec 31, 2024 −$5.74M
Gross Profit FY 2025 · Dec 31, 2025 $3.81K
Gross Profit FY 2025 · Dec 31, 2024 $6.6K
Cost Of Revenue FY 2025 · Dec 31, 2025 $2.19K
Cost Of Revenue FY 2025 · Dec 31, 2024 $4.4K
Revenue FY 2025 · Dec 31, 2025 $6K
Revenue FY 2025 · Dec 31, 2024 $11K